Valuation: Avantor, Inc.

Market Cap 975.31Cr 835.74Cr 783.11Cr 715.32Cr 1.35TCr 93TCr 1.36TCr 9.24TCr 3.6TCr 47TCr 3.66TCr 3.58TCr 1,55400Cr P/E 2026 *
43.2x
P/E 2027 * 30.9x
Enterprise Value 1.28TCr 1.1TCr 1.03TCr 940.66Cr 1.78TCr 1,22300Cr 1.79TCr 12TCr 4.73TCr 62TCr 4.82TCr 4.71TCr 2,04300Cr EV / Sales 2026 *
1.95x
EV / Sales 2027 * 1.81x
Free-Float
95.5%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 18/08/2025
Director of Finance/CFO 50 24/06/2026
Chief Operating Officer - 10/11/2025
Director TitleAgeSince
Director/Board Member 60 22/04/2020
Chairman 69 01/01/2026
Director/Board Member 62 01/10/2021
Date Insider Type Main position Quantity % Market Cap.
18/08/26 Tax

Chief Executive Officer

-29,803 0.0044%
14/08/26 Tax

Head of Human Resources

-181 0.0000%
31/07/26 Tax

Chief Financial Officer

-1,385 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+1.12%+8.18% - - 975.31Cr
-0.46%+3.06%-11.94%+11.44% 20TCr
-1.89%-1.03%-0.98%+10.89% 12TCr
+1.33%+3.77%+13.79%+82.78% 6.26TCr
-0.12%-1.77%+29.62%+56.62% 5.25TCr
-0.50%+4.98%-2.50%-32.22% 5.17TCr
-2.09%-0.49%+17.38%-11.51% 3.36TCr
+2.71%+4.45% - - 3.13TCr
-1.37%+0.55%+40.97%-11.49% 2.45TCr
-0.94%+4.05%-2.80%+19.77% 2.4TCr
Average -0.34%+2.07%+10.44%+15.78% 6.08TCr
Weighted average by Cap. -0.27%+1.64%+2.29%+17.41%

Financials

2026 *2027 *
Net sales 659.37Cr 565.01Cr 529.43Cr 483.6Cr 912.67Cr 63TCr 921.67Cr 6.24TCr 2.43TCr 32TCr 2.48TCr 2.42TCr 1,05000Cr 674.97Cr 578.38Cr 541.95Cr 495.04Cr 934.26Cr 64TCr 943.48Cr 6.39TCr 2.49TCr 32TCr 2.53TCr 2.48TCr 1,07500Cr
Net income 23Cr 19Cr 18Cr 17Cr 31Cr 2.15TCr 31Cr 213.23Cr 83Cr 1.08TCr 85Cr 83Cr 3.59TCr 31Cr 27Cr 25Cr 23Cr 43Cr 2.96TCr 43Cr 294.34Cr 114.58Cr 1.49TCr 116.69Cr 114.15Cr 4.95TCr
Net Debt 307.24Cr 263.28Cr 246.69Cr 225.34Cr 425.27Cr 29TCr 429.46Cr 2.91TCr 1.13TCr 15TCr 1.15TCr 1.13TCr 49TCr 244.13Cr 209.19Cr 196.02Cr 179.05Cr 337.91Cr 23TCr 341.24Cr 2.31TCr 900.1Cr 12TCr 916.66Cr 896.69Cr 39TCr
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company's segments include Bioscience & Medtech Products and VWR Distribution & Services. Through these segments, it provides materials and consumables, equipment and instrumentation and services and specialty procurement to customers in biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and others.
Employees
13,500
Date Price Change Volume
25/26/25 $14.42 +1.12% 55,55,186
24/26/24 $14.26 -1.38% 51,92,724
21/26/21 $14.46 +1.47% 60,63,680
20/26/20 $14.25 +2.08% 71,30,643
19/26/19 $13.96 +4.73% 64,21,212
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
14.42USD
Average target price
14.56USD
Spread / Average Target
+1.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AVTR Stock